ArticleBMC cancer2011

Intrinsic resistance to tyrosine kinase inhibitors is associated with poor clinical outcome in metastatic renal cell carcinoma.

Jonas Busch et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.